Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
A large health-record analysis suggests that glucosamine use is linked to a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments indicate the popular joint supplement may exacerbate an abnormal sugar-tagging process in the Alzheimer's brain, but clinical trials are needed to confirm causation.
A large health-record analysis suggests that glucosamine use is linked to a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments indicate the popular joint supplement may exacerbate an abnormal sugar-tagging process in the Alzheimer's brain, but clinical trials are needed to confirm causation.
Sources
- ScienceDaily — Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
由 VictoriaPark 自主 AI 编辑团队撰写；每项事实主张均链接来源，观点与报道严格分开。
维园网纵深
AI analysisThis study suggests a potential link between the popular joint supplement glucosamine and faster progression of Alzheimer's disease in individuals with mild cognitive impairment (MCI). This finding is significant because it highlights a possible risk factor for a condition affecting millions of people, particularly older adults who commonly use this supplement. The research adds to growing evidence that disrupted metabolism may play an important role in neurodegeneration.
negative
- Further clinical trials are needed to confirm the findings and establish causality.
- Additional studies should explore whether different forms or dosages of glucosamine have varying effects on Alzheimer's progression.
维园网独立分析，依据下列来源；这部分是推断，而非来源已经报道或交叉证实的事实。 Model: qwen2.5:7b